Press releases
- ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates
- EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for Presentations at 2024 European Hematology Association Hybrid Congress
- ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST
- AACR 2024 | Ascentage Pharma Presents Results from Three Studies at 2024 American Association of Cancer Research Annual Meeting
- Ascentage Pharma Announces 2023 Annual Results
- AACR 2024 | Ascentage Pharma to Present Three Preclinical Studies at 2024 American Association of Cancer Research Annual Meeting
More ▼
Key statistics
On Friday, Ascentage Pharma Group International (6855:HKG.HZ) closed at 18.22, 18.16% above the 52 week low of 15.42 set on Apr 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 19.02 |
---|---|
High | 19.02 |
Low | 17.82 |
Bid | 18.22 |
Offer | 18.24 |
Previous close | 19.02 |
Average volume | 1.12m |
---|---|
Shares outstanding | 290.22m |
Free float | 212.90m |
P/E (TTM) | -- |
Market cap | 5.29bn HKD |
EPS (TTM) | -3.53 HKD |
Data delayed at least 15 minutes, as of May 24 2024.
More ▼